Personalization of mathematical models of human atrial action potential

Atrial cardiomyocytes demonstrate a wide spectrum of patient-specific, tissue-specific, and pathology-specific action potential (AP) phenotypes due to differences in protein expression and posttranslational modifications. Accurate simulation of the AP excitation and propagation in healthy or diseased atria requires a mathematical model capable of reproducing all the differences by parameter rescaling. In the present study, we have benchmarked two widely used electrophysiological models of the human atrium: the Maleckar and the Grandi models. In particular, patch-clamp AP recordings from human atrial myocytes were fitted by the genetic algorithm (GA) to test the models' versatility. We have shown that the Maleckar model results in a more accurate fitting of heart rate dependence of action potential duration (APD) and resting potential (RP). On the other hand, both models demonstrate the poor fitting of the plateau phase and spike-and-dome morphologies. We propose that modifications to L-type calcium current-voltage relationships are required to improve atrial models' fidelity.

[1]  Gernot Plank,et al.  A work flow to build and validate patient specific left atrium electrophysiology models from catheter measurements , 2018, Medical Image Anal..

[2]  K. Aras,et al.  Genetic algorithm-based personalized models of human cardiac action potential , 2019, bioRxiv.

[3]  J. Nerbonne,et al.  Atrial L-type Ca2+ currents and human atrial fibrillation. , 1999, Circulation research.

[4]  Igor R. Efimov,et al.  Critical Volume of Human Myocardium Necessary to Maintain Ventricular Fibrillation , 2018, Circulation. Arrhythmia and electrophysiology.

[5]  B. Fermini,et al.  Differences in rate dependence of transient outward current in rabbit and human atrium. , 1992, The American journal of physiology.

[6]  S. Nattel,et al.  Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy , 2020, Circulation research.

[7]  J. Magyar,et al.  Effects of endothelin-1 on calcium and potassium currents in undiseased human ventricular myocytes , 2000, Pflügers Archiv.

[8]  Stanley Nattel,et al.  Regional and tissue specific transcript signatures of ion channel genes in the non‐diseased human heart , 2007, The Journal of physiology.

[9]  Yoram Rudy,et al.  Simulation of the Undiseased Human Cardiac Ventricular Action Potential: Model Formulation and Experimental Validation , 2011, PLoS Comput. Biol..

[10]  Joseph L Greenstein,et al.  Mathematical simulations of ligand-gated and cell-type specific effects on the action potential of human atrium. , 2008, Progress in biophysics and molecular biology.

[11]  D. Dobrev,et al.  Role of IKur in Controlling Action Potential Shape and Contractility in the Human Atrium: Influence of Chronic Atrial Fibrillation , 2004, Circulation.

[12]  Mathias Wilhelms,et al.  Benchmarking electrophysiological models of human atrial myocytes , 2013, Front. Physio..

[13]  M. Chung,et al.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[14]  S Nattel,et al.  Properties of human atrial ICa at physiological temperatures and relevance to action potential. , 1997, The American journal of physiology.

[15]  F. Mason,et al.  Altered atrial cytosolic calcium handling contributes to the development of postoperative atrial fibrillation , 2020, Cardiovascular research.

[16]  Na Li,et al.  Cellular and Molecular Mechanisms of Atrial Arrhythmogenesis in Patients With Paroxysmal Atrial Fibrillation , 2014, Circulation.

[17]  D. Levy,et al.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.

[18]  J. Jalife,et al.  Human Atrial Action Potential and Ca2+ Model: Sinus Rhythm and Chronic Atrial Fibrillation , 2011, Circulation research.

[19]  Carlos Sánchez,et al.  Inter-Subject Variability in Human Atrial Action Potential in Sinus Rhythm versus Chronic Atrial Fibrillation , 2014, PloS one.

[20]  T. Wieland,et al.  Enhanced Sarcoplasmic Reticulum Ca2+ Leak and Increased Na+-Ca2+ Exchanger Function Underlie Delayed Afterdepolarizations in Patients With Chronic Atrial Fibrillation , 2012, Circulation.

[21]  M. Borggrefe,et al.  Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation , 2015, Circulation.

[22]  R F Bosch,et al.  Ionic mechanisms of electrical remodeling in human atrial fibrillation. , 1999, Cardiovascular research.

[23]  M. Borggrefe,et al.  Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy , 2017, European heart journal.

[24]  Stefano Severi,et al.  Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block , 2019, eLife.

[25]  Nolwenn Le Meur,et al.  Human Atrial Ion Channel and Transporter Subunit Gene-Expression Remodeling Associated With Valvular Heart Disease and Atrial Fibrillation , 2005, Circulation.

[26]  Godfrey L. Smith,et al.  Dynamic clamping human and rabbit atrial calcium current: narrowing I CaL window abolishes early afterdepolarizations , 2019, The Journal of physiology.

[27]  Stefan L. Zimmerman,et al.  Computationally guided personalized targeted ablation of persistent atrial fibrillation , 2019, Nature Biomedical Engineering.